Cargando…

Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy

CD19-specific chimeric antigen receptor (CAR) T cell therapy has changed the treatment paradigm for pediatric, adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, data on the associated infectious disease challenges in this patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maron, Gabriela M., Hijano, Diego R., Epperly, Rebecca, Su, Yin, Tang, Li, Hayden, Randall T., Naik, Swati, Karol, Seth E., Gottschalk, Stephen, Triplett, Brandon M., Talleur, Aimee C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959860/ https://www.ncbi.nlm.nih.gov/pubmed/35356197 http://dx.doi.org/10.3389/fonc.2022.845540

Ejemplares similares

CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL
por: Epperly, Rebecca, et al.
Publicado: (2023)

Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemia
por: Petgrave, Yonique P, et al.
Publicado: (2023)

Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant
por: Hijano, Diego R., et al.
Publicado: (2018)

A tour de force provides novel insights into CD19-CAR T cell resistance mechanisms
por: Talleur, Aimee C., et al.
Publicado: (2023)

CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia
por: Zebley, Caitlin C., et al.
Publicado: (2021)

Allogeneic CAR Cell Therapy—More Than a Pipe Dream
por: Caldwell, Kenneth J., et al.
Publicado: (2021)

Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution
por: Mamcarz, Ewelina, et al.
Publicado: (2019)

Selective depletion of naïve T cells by targeting CD45RA
por: Naik, Swati, et al.
Publicado: (2023)

Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond
por: Epperly, Rebecca, et al.
Publicado: (2020)

A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy
por: Epperly, Rebecca, et al.
Publicado: (2020)

Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
por: Wilson, Taylor L., et al.
Publicado: (2022)

Preferential expansion of CD8(+) CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL
por: Talleur, Aimee C., et al.
Publicado: (2022)

Clinical correlation of influenza and respiratory syncytial virus load measured by digital PCR
por: Hijano, Diego R., et al.
Publicado: (2019)

Infectious complications of CAR T-cell therapy: a clinical update
por: Stewart, Adam G., et al.
Publicado: (2021)

Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia
por: Mo, George, et al.
Publicado: (2020)

Anakinra utilization in refractory pediatric CAR T-cell associated toxicities
por: Diorio, Caroline, et al.
Publicado: (2022)

925. Infectious Complications Following Chimeric Antigen Receptor (CAR) T-cell Therapy
por: Trottier, Caitlin, et al.
Publicado: (2021)

Clinical Correlation of Adenoviral Load in the Respiratory Tract Measured by Digital PCR in Immunocompromised Children
por: Hijano, Diego R, et al.
Publicado: (2023)

1105. The Burden of Infections Prior to Chimeric Antigen Receptor (CAR) Modified T-cell Therapy Predicts Post-CAR T-cell Infectious Complications
por: Garner, Will, et al.
Publicado: (2020)

Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
por: Kambhampati, Swetha, et al.
Publicado: (2022)

2694. Infectious Complications in CAR-T Cell Therapy Recipients: A Systematic Review and Meta-Analysis
por: Banegas, Marcela, et al.
Publicado: (2023)

Complications after CD19+ CAR T-Cell Therapy
por: Penack, Olaf, et al.
Publicado: (2020)

Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
por: Sheih, Alyssa, et al.
Publicado: (2020)

A nucleic acid amplification test‐based strategy does not help inform return to work for healthcare workers with COVID‐19
por: Hijano, Diego R., et al.
Publicado: (2022)

Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy
por: Takagi, Kosei, et al.
Publicado: (2017)

Infectious Norovirus Is Chronically Shed by Immunocompromised Pediatric Hosts
por: Davis, Amy, et al.
Publicado: (2020)

Analysis of early infectious complications in pediatric patients undergoing bone marrow transplantation
por: Busca, A., et al.
Publicado: (1999)

Incidence of Infectious Diseases during the Puri Car Festival, 1946
por: Misra, K. N.
Publicado: (1946)

Antibiotic prophylaxis and infectious complications in patients on peritoneal dialysis undergoing lower gastrointestinal endoscopy
por: Clarke, William T, et al.
Publicado: (2020)

2690. Infectious Complications in Adult Leukemic Patients with Prolonged Neutropenia Undergoing Induction Chemotherapy
por: Sabapathy, Vidhya, et al.
Publicado: (2019)

Necessity of early and continuous monitoring for possible infectious complications in children undergoing therapeutic hypothermia
por: Brandt, Jennifer B., et al.
Publicado: (2020)

Infectious Complications
por: Strasfeld, Lynne
Publicado: (2014)

Non-infectious Pulmonary Complications in Children with Primary Immunodeficiency
por: Mongkonsritragoon, Wimwipa, et al.
Publicado: (2023)

CD47 expression is critical for CAR T-cell survival in vivo
por: Beckett, Alex N, et al.
Publicado: (2023)

Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy
por: Obaisi, Obada, et al.
Publicado: (2022)

Neurological updates: neurological complications of CAR-T therapy
por: Tallantyre, Emma C., et al.
Publicado: (2020)

CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells
por: Hebbar, Nikhil, et al.
Publicado: (2022)

A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy
por: Ragoonanan, Dristhi, et al.
Publicado: (2022)

Infectious complications following CAR-t cell therapy for B cell non-Hodgkin lymphoma: a single-center experience and review of the literature
por: Mercadal, Santiago, et al.
Publicado: (2023)

CAR T Cells Beyond Cancer: Hope for Immunomodulatory Therapy of Infectious Diseases
por: Seif, Michelle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f623188hbik3jla5p22itjp61e